These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25577888)

  • 1. Compounding practices in a Portuguese community pharmacy.
    Reis M; Carvalho M; Rodrigues A
    Int J Pharm Compd; 2014; 18(5):392-5. PubMed ID: 25577888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical Compounding in Portuguese Community Pharmacies: CHARACTERIZATION AND FUTURE PERSPECTIVES.
    Palmeira-de-Oliveira R; Macedo M; Machado RM; Pacheco AF; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; Duarte P
    Int J Pharm Compd; 2016; 20(2):114-22. PubMed ID: 27323423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies.
    Buurma H; de Smet PA; van den Hoff OP; Sysling H; Storimans M; Egberts AC
    Pharm World Sci; 2003 Dec; 25(6):280-7. PubMed ID: 14689817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Improving the quality of compounded medicines through self-assessment: proof of concept].
    Wauters K; Fierens C; Corthout J; Sarre S; Saevels J
    J Pharm Belg; 2014 Jun; (2):26-33. PubMed ID: 25055453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in compounding of oral liquids for pediatric patients: a patient safety concern.
    Rood JM; Engels MJ; Ciarkowski SL; Wagenknecht LD; Dickinson CJ; Stevenson JG
    J Am Pharm Assoc (2003); 2014; 54(4):383-9. PubMed ID: 25063260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies.
    AlKhatib HS; Jalouqa S; Maraqa N; Ratka A; Elayeh E; Al Muhaissen S
    BMC Health Serv Res; 2019 Nov; 19(1):816. PubMed ID: 31703672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy.
    Karara AH; Hines R; Demir Z; Nnorom B; Horsey R; Twigg G
    Int J Pharm Compd; 2016; 20(6):461-467. PubMed ID: 28339384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine.
    Zaid AN; Al-Ramahi R; Shahed Q; Saleh B; Elaraj J
    Int J Pharm Pract; 2012 Feb; 20(1):9-14. PubMed ID: 22236175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Practical guidelines to ensure the quality of compounded preparations in community pharmacies].
    Wauters K; Vandeputte A; De Paepe K
    J Pharm Belg; 2017 Mar; (1):14-24. PubMed ID: 30281230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Extemporaneous Prescriptions Prescribed by Dermatovenerologists in Latvia and Comparison with Standardized Compounded Preparation Monographs of Germany and USA.
    Kiseļova O; Mauriņa B; Šidlovska V
    Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31936697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community pharmacy services in Portugal.
    Costa S; Santos C; Silveira J
    Ann Pharmacother; 2006 Dec; 40(12):2228-34. PubMed ID: 17148652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practices of pharmacies that compound extemporaneous formulations.
    Treadway AK; Craddock D; Leff R
    Am J Health Syst Pharm; 2007 Jul; 64(13):1403-9. PubMed ID: 17592006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of compounded oral liquids for pediatric patients in Michigan.
    Engels MJ; Ciarkowski SL; Rood J; Wang B; Wagenknecht LD; Dickinson CJ; Stevenson JG
    Am J Health Syst Pharm; 2016 Jul; 73(13):981-90. PubMed ID: 27325879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing specialized compounding in community pharmacies.
    Giam JA; McLachlan AJ; Krass I
    Res Social Adm Pharm; 2012; 8(3):240-52. PubMed ID: 21824824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the most frequently prescribed extemporaneously compounded medications in a rural setting: a case study from the Delmarva Peninsula.
    Sherr Z; Karara AH
    Int J Pharm Compd; 2014; 18(6):462-8. PubMed ID: 25906622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The standardization of nonsterile compounding: a study in quality control and assessment for hormone compounding.
    Wiley TS; Odegard RD; Raden J; Haraldsen JT
    Int J Pharm Compd; 2014; 18(2):162-8. PubMed ID: 24881121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Devices for securing and administering pediatric compounded oral liquids: survey results from French university hospitals.
    Cavelier M; Hervouët C; Varin R; Gondé H
    Eur J Pediatr; 2024 Jun; 183(6):2805-2810. PubMed ID: 38573361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical compounding or pharmaceutical manufacturing? A regulatory perspective.
    Timko RJ; Crooker PE
    Int J Pharm Compd; 2014; 18(2):101-11. PubMed ID: 24881112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Trends and Emerging Priorities in Compounded Preparations for Children.
    Parrish RH
    Int J Pharm Compd; 2018; 22(5):358-366. PubMed ID: 30384335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.